NRG-GY037

ACTIVATION NOTICE


NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer is now open to accrual.


Documents are posted on CTSU.

 


Facebook  X  Instagram  LinkedIn  YouTube